期刊文献+

天花粉蛋白、米非司酮和顺铂对卵巢癌细胞HLA-G表达的影响 被引量:1

The effects of trichosanthin,mifepristone,cisplatin on the expression of HLA-G in ovarian cancer cells
下载PDF
导出
摘要 目的检测HLA-G在卵巢癌细胞中表达情况,探讨天花粉蛋白、米非司酮、顺铂是否能够通过下调HLA-G的表达,达到抑制肿瘤生长的目的。方法采用RT-PCR技术检测卵巢癌卵巢浆液性囊腺癌(SKOV3)、卵巢粘液性囊腺癌(3AO)、卵巢腺癌细胞株(OVCAR3)细胞中HLA-G表达情况,选择出表达HLA-G阳性的细胞株。MTT技术观察不同浓度天花粉蛋白、米非司酮、顺铂对该细胞体外生长增殖能力的影响及对细胞中HLA-GmRNA表达水平的影响。结果卵巢癌OVCAR3细胞株表达HLA-G为阳性,SKOV3和3AO细胞表达均为阴性;天花粉蛋白、米非司酮、顺铂均能抑制OVCAR3细胞生长,并呈浓度依赖性;天花粉蛋白、米非司酮均能明显下调OVCAR3细胞中HLA-GmRNA表达水平(P<0.05),而顺铂对OVCAR3细胞中HLA-GmRNA表达无明显影响(P>0.05)。结论天花粉蛋白、米非司酮和顺铂都具有抑制卵巢癌细胞生长的作用,前二者治疗卵巢癌的作用机制同顺铂有所不同,与顺铂联合应用,可能会取得更好的治疗效果。 Objective To observe the expression of HLA-G in ovarian cancer cells and to explore whether the expression of HLA-G can be down-regulated by trichosanthin,mifepristone and cisplatin,resulting in the inhibition effect on tumor growth.Methods RT-PCR was used to detect the expression of HLA-G in human ovarian cancer SKOV3,3AO,OVCAR3 cells and the HLA-G mRNA levels after these cells were treated with trichosanthin,mifepristone,cisplatin respectively.The MTT method was performed to observe the influence of the three drugs on the proliferation of ovarian cancer cells.Results The expression of HLA-G mRNA was positive only in OVCAR3 cells.The trichosanthin,mifepristone,cisplatin inhibited the proliferation of ovarian cancer cells obviously,and the inhibition rate was dependent on the drug concentration.Trichosanthin and mifepristone could down-regulate HLA-G mRNA levels significantly,but the difference for cisplatin was not significant.Conclusion Trichosanthin,mifepristone,cisplatin can inhibit the growth of ovarian cancer cells obviously.The anti-tumor action mechanism of trichosanthin and mifepristone is different from that of cisplatin,and the combination application of cisplatin and trichosanthin or mifepristone can obtain better therapeutic effect.
出处 《河北医药》 CAS 2011年第9期1285-1287,共3页 Hebei Medical Journal
基金 河北省科学技术研究与发展支撑计划项目(编号:08276101D-78)
关键词 卵巢癌 HLA-G 天花粉蛋白 米非司酮 顺铂 ovarian cancer HLA-G trichosanthin mifepristone cisplatin
  • 相关文献

参考文献8

二级参考文献57

共引文献64

同被引文献14

  • 1Pabla N,Dong Z. Cisplatin nephrotoxicity:mechanisms and renoprotective strategies[J]. Kidney Int, 2008,73(9) :994-1007.
  • 2Lin X, Howell SB. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance[J]. Mol Cancer Ther, 2006,5 ( 5 ) : 1239- 1247.
  • 3Liu H, Wang Y, Song Q, et al. TFAR19, a novel apoptosis-related gene cloned from human Leukemia cell line TF-1, could enhance apoplosis of some tumor cells induced by growth factor withdrawal [J].Biochem Biophys Res Commun, 1999,254 ( 1 ) : 203-210.
  • 4Li QQ,Wang G,Reed E,et al. Evaluation of Cisplatin in Combination with beta-Elemene as a Regimen for Prostate Cancer Chemotherapy[J]. Basic Clin Pharmacol Toxicol, 2010, 107(5):868-876.
  • 5Noel EE, Yeste-Velasco M, Mao X, et al. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers[J]. Am J Pathol,2010,176(6) :2607-2615.
  • 6Chen C.Zhou H, Xu L, et al. Recombinant human PDCD5 sensitizes ehondrosareomas to cisplatin chemotherapy in vitro and in vivo[J]. Apoptosis,2010,15(7):805-813.
  • 7Zhang X, Wang X, Song X. et al. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas [J]. Oncol Rep,2011,25(2) :353 358.
  • 8Rui M,Chen Y,Zhang Y,et al. Transfer of anti-TFAR19 monoclonal antibody into Hel.a cells by in situ electroporation can inhibit the apoptosis[J]. Life Sci,2002,71(15) :1771-1778.
  • 9Yin A,Jiang Y,Zhang X,et al. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-indueed apoptosis in vitro and in vivo [J]. Eur J Pharmacol,2010,649(1-3) :120-126.
  • 10Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery[J]. Nat Rev Cancer,2005,5(11) :876-885.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部